Formative—Threshold Pharmaceuticals 2004 Annual Report & Form 10K:

Contact Us	Free Donuts	Search the Site	Sitemap	Workroom







Investor Relations Sunesis Threshold United Commercial Bank (UCBH) Netflix Fair, Isaac Chiron Onyx Barra Solectron PeopleSoft ALZA Caliper Technologies Aradigm ProBusiness Protein Design Labs Union Bank Foundation Sangamo BioSciences The Asia Foundation The California Endowment BioTime			Formative—Threshold Pharmaceuticals 2004 Annual Report & Form 10K: Threshold Pharmaceuticals has had a remarkable year. Not only did they drive forward with significant developments with their Metabolic Targeting therapies, but they succeeded in taking the company public in a challenging economic environment. The company is focusing on the treatment of pancreatic cancer and Benign Prostatic Hyperplasia by targeting the fundamental differences in glucose metabolism between normal cells and diseased cells — a unique and promising approach for significant unmet medical needs. Threshold has 3 products in advanced trials — quite an accomplishment for a young company. We were able to manage a very tight deadline, budget, and review process while still shooting some custom photography of their lead product. Threshold 2005 Annual Report About Threshold